- Home
- SCYX vs HKIT Comparison
SCYX vs HKIT Comparison
Compare SCYX & HKIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCYX
- HKIT
- Stock Information
- Founded
- SCYX 1999
- HKIT 1996
- Country
- SCYX United States
- HKIT China
- Employees
- SCYX N/A
- HKIT N/A
- Industry
- SCYX Biotechnology: Pharmaceutical Preparations
- HKIT Computer Software: Prepackaged Software
- Sector
- SCYX Health Care
- HKIT Technology
- Exchange
- SCYX Nasdaq
- HKIT Nasdaq
- Market Cap
- SCYX 34.9M
- HKIT 39.8M
- IPO Year
- SCYX 2014
- HKIT 2023
- Fundamental
- Price
- SCYX $0.83
- HKIT $1.48
- Analyst Decision
- SCYX
- HKIT
- Analyst Count
- SCYX 0
- HKIT 0
- Target Price
- SCYX N/A
- HKIT N/A
- AVG Volume (30 Days)
- SCYX 167.5K
- HKIT 13.0K
- Earning Date
- SCYX 08-13-2025
- HKIT 10-27-2025
- Dividend Yield
- SCYX N/A
- HKIT N/A
- EPS Growth
- SCYX N/A
- HKIT N/A
- EPS
- SCYX N/A
- HKIT N/A
- Revenue
- SCYX $3,257,000.00
- HKIT $2,904,950.00
- Revenue This Year
- SCYX $422.61
- HKIT N/A
- Revenue Next Year
- SCYX $240.56
- HKIT N/A
- P/E Ratio
- SCYX N/A
- HKIT N/A
- Revenue Growth
- SCYX N/A
- HKIT N/A
- 52 Week Low
- SCYX $0.66
- HKIT $1.15
- 52 Week High
- SCYX $1.66
- HKIT $1.79
- Technical
- Relative Strength Index (RSI)
- SCYX 54.46
- HKIT 48.78
- Support Level
- SCYX $0.82
- HKIT $1.48
- Resistance Level
- SCYX $0.88
- HKIT $1.54
- Average True Range (ATR)
- SCYX 0.04
- HKIT 0.03
- MACD
- SCYX -0.00
- HKIT -0.01
- Stochastic Oscillator
- SCYX 48.45
- HKIT 9.90
About SCYX SCYNEXIS Inc.
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
About HKIT Hitek Global Inc.
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.